Table 3.
Frequencies of cancer type.
| Cancer type | Jung et al.
12
N = 19 ǂ |
Lee et al. 2019
13
N = 26 |
Ozaki et al.
14
N = 18 |
Lee et al. 2021
15
N = 34 |
Ciolli et al.
16
N = 14 |
Cho et al.
17
N = 27 |
Verschoof et al.
18
N = 124 |
Total N = 262 |
|---|---|---|---|---|---|---|---|---|
| Hepatobiliary | 5 (26) | 6 (26) | – | 8 (24) | 1 (7) | 7 (26) | – | 27 (10) |
| Lung | 7 (37) | 3 (12) | 2 (10) | 7 (21) | 2 (14) | 6 (22) | 31 (25) | 58 (22) |
| GI | – | 9 (35) | 1 (6) | 5 (15) | 2 (14) | 7 (16) | 41 (33) | 65 (25) |
| GU | – | 3 (12) | 9 (50) | 3 (9) | 5 (36) | 3 (11) | 26 (21) | 49 (19) |
| Breast | – | – | 4 (22) | 2 (6) | 1 (7) | 1 (4) | 16 (13) | 25 (10) |
| Pancreatic | – | 2 (8) | 1 (6) | 9 (26) | 2 (14) | – | – | 14 (5) |
| Hematologic | – | 2 (8) | 1 (6) | – | 1 (7) | 3 (11) | 3 (2) | 10 (4) |
| Thyroid | – | 1 (4) | – | – | – | – | – | 1 (0.4) |
| Other | – | – | – | – | – | – | 7 (6)* | 4 (2) |
Values are Number (%); GI: Gastrointestinal (salivary gland, gastric, colorectal, esophageal); GU: Genitourinary (ovarian, renal, prostate, bladder); Hepatobiliary: gall bladder, bile duct, hepatic.
*
Metastases from unknown primary tumor (2), malignant tumor lower leg (1, histopathological findings not reported), melanoma (3), sarcoma central pulmonary artery (1).
ǂ
Seven missings.